Advances in biology and therapy of multiple myeloma - genes and proteins of myeloma endothelial cells

ISCRIVITI ALLA NEWSLETTER

trattati copertine

Advances in experimental medicine and biology - could multiple myeloma vegf modify the systemic microcirculation?

In questo capitolo, Vacca et al. descrivono il ruolo del VEGF, noto per il suo effetto pro- angiogenico, nell’indurre modificazioni del microcircolo in pazienti affetti da mieloma multiplo e da MGUS.

Angiogenesis, lymphangiogenesis and clinical implications – Angiogenesis in multiple myeloma

International review of cell and molecular biology – Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis

Advances in experimental medicine and biology - could multiple myeloma vegf modify the systemic microcirculation?

Multiple myeloma-angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells

Frontiers in anti-cancer drug discovery- Thimidine phosphorylase/platelet-derived endothelial cell growth factor as a target for capecitabine: from biology to the bedside

Research on melanoma - Role of angiogenesis in melanoma progression

Cell respiration and cell survival- The bone marrow microenvironment in multiple myeloma: cellular and molecular basis of disease progression

Cytochines mechanisms, functions and abnormalities- Vascular endothelial growth factor and its receptors in multiple myeloma

Neoplasie dell’anziano – cancro e trombosi nell’anziano: risultati del trattamento combinato - chemioterapia ed eparina a basso peso molecolare - in un paziente con carcinoma polmonare

Chirurgia vascolare ed endovascolare – Trattamento medico delle malattie vascolari

Multiple myeloma: a new era of treatment strategies - Multiple myeloma bone marrow angiogenesis

Recent advances in angiogenesis and antiangiogenesis- Role of stromal cells in neovascularization of multiple myeloma

Multiple myeloma risk factors, diagnosis and treatment- New drugs and new strategies for the treatment of multiple myeloma Patients

Zoledronic acid clinical uses, therapeutic effects and Pharmacokinetics - clinical and experimental evidences of anti-myeloma activities of zoledronic acid

Advances in experimental medicine and biology - could multiple myeloma vegf modify the systemic microcirculation?

Frontiers in anti-cancer drug discovery – bortezomib in the treatment of cancer

Systemic vasculitidies: current status and perspectives

Angiogenesis: an integrative approach from science to medicine- Overview of angiogenesis during tumor growth

Angelo Vacca, MD, PhD

Professor of Medicine
Department of Biomedical Sciences and Human Oncology
Chief Clinica Medica "G. Baccelli"
University of Bari Medical School
I-70124 BARI (Italy)

Phone +39-080-5478057
Fax +39-080-5592189
e-mail angelo.vacca@uniba.it

RICHIEDI UN APPUNTAMENTO